In vitro Lipolysis: An Indispensable Tool for the Development of IVIVC of Lipid Based Drug Delivery Systems

Simple item page
dc.contributor.authorSinghvi, Gautam
dc.date.accessioned2024-01-10T07:12:56Z
dc.date.available2024-01-10T07:12:56Z
dc.date.issued2017
dc.description.abstractAround 70% of the pipeline drugs and 40% of marketed drugs come under the BCS class of II and IV. Dissolution of these drugs is a major concern for formulation scientists as poorly soluble drugs consequently affects the bioavailavbility, thus reducing the therapeautic efficacy of these drugsen_US
dc.identifier.urihttps://benthamscience.com/article/86060
dc.identifier.urihttp://dspace.bits-pilani.ac.in:8080/xmlui/handle/123456789/13774
dc.language.isoenen_US
dc.publisherBentham Scienceen_US
dc.subjectPharmacyen_US
dc.subjectIVIVCen_US
dc.subjectLipolysisen_US
dc.subjectLipid based drug delivery systemsen_US
dc.subjectBiopharmaceutical Classification System (BCS)en_US
dc.subjectIn vitro characterisationen_US
dc.titleIn vitro Lipolysis: An Indispensable Tool for the Development of IVIVC of Lipid Based Drug Delivery Systemsen_US
dc.typeArticleen_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Department of Pharmacy